Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Laura Fachal
Based on 12 articles published since 2009
(Why 12 articles?)
||||
Expertise Level
The expertise of Laura Fachal ranks in the
  • Top 1.4%
  • ... of 287,191 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 12 articles on the topic.
Graphical view (beta)
Aliases Fachal, L   ·   Fachal, Laura
Work Locations
Details
Most likely:    University of Cambridge      
2019
  • Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK. Electronic address: · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK; Department of Electron Microscopy/Molecular Pathology, The Cyprus Institute of Neurology and Genetics, 1683 Nicosia, Cyprus. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK. · Department of Mathematics and Statistics, Laval University, Québec City, QC G1V 0A6, Canada. · Family Cancer Clinic, the Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Amsterdam, 1066 CX, the Netherlands. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20850, USA. · Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki 00290, Finland. · Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada. · Department of Epidemiology, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, CA 92617, USA. · NN Alexandrov Research Institute of Oncology and Medical Radiology, Minsk 223040, Belarus. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany. · Department of Public Health Sciences, and Cancer Research Institute, Queen's University, Kingston, ON K7L 3N6, Canada. · Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, WI 53205, USA. · Cancer Center, Kuopio University Hospital, Kuopio 70210, Finland; Institute of Clinical Medicine, Oncology, University of Eastern Finland, Kuopio 70210, Finland; Translational Cancer Research Area, University of Eastern Finland, Kuopio 70210, Finland. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen 91054, Germany. · Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain; Biomedical Network on Rare Diseases (CIBERER), Madrid 28029, Spain. · Institute of Biochemistry and Genetics, Ufa Scientific Center of Russian Academy of Sciences, Ufa 450054, Russia. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA. · Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki 00290, Finland; Department of Oncology, Örebro University Hospital, Örebro 70185, Sweden. · NN Alexandrov Research Institute of Oncology and Medical Radiology, Minsk 223040, Belarus; Department of Radiation Oncology, Hannover Medical School, Hannover 30625, Germany; Gynaecology Research Unit, Hannover Medical School, Hannover 30625, Germany. · Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev 2730, Denmark; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev 2730, Denmark; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2200, Denmark. · Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan 20141, Italy. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo 0379, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo 0450, Norway. · Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart 70376, Germany; University of Tübingen, Tübingen 72074, Germany; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg 69120, Germany. · Department of Radiation Oncology, Hannover Medical School, Hannover 30625, Germany. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg 69120, Germany; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg 69120, Germany. · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London EC1M 6BQ, UK. · Sheffield Institute for Nucleic Acids (SInFoNiA), Department of Oncology and Metabolism, University of Sheffield, Sheffield S10 2TN, UK. · Genome Sciences Centre, BC Cancer Agency, Vancouver, BC V5Z 1L3, Canada; Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, BC V5A 1S6, Canada. · Department of Gynecology and Obstetrics, University of Tübingen, Tübingen 72076, Germany. · Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum 44789, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg 69120, Germany; Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany; Department of Biology, University of Pisa, Pisa 56126, Italy. · Epidemiology Research Program, American Cancer Society, Atlanta, GA 30303, USA. · Oncology and Genetics Unit, Instituto de Investigacion Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo 36312, Spain. · Division of Medical Oncology and Hematology, University of California at Los Angeles, Los Angeles, CA 90024, USA. · Westmead Institute for Medical Research, University of Sydney, Sydney, NSW 2145, Australia. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam 3015 CN, the Netherlands. · Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif 94805, France. · Division of Molecular Pathology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam 1066 CX, the Netherlands. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield S10 2TN, UK. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 171 65, Sweden. · Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. · Department of Pathology, Leiden University Medical Center, Leiden 2333 ZA, the Netherlands; Department of Human Genetics, Leiden University Medical Center, Leiden 2333 ZA, the Netherlands. · Gynaecology Research Unit, Hannover Medical School, Hannover 30625, Germany. · Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK. · Genomics Center, Centre Hospitalier Universitaire de Québec - Université Laval Research Center, Université Laval, Québec City, QC G1V 4G2, Canada. · Southampton Clinical Trials Unit, Faculty of Medicine, University of Southampton, Southampton SO17 6YD, UK; Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton SO17 6YD, UK. · School of Life Sciences, University of Westminster, London W1B 2HW, UK. · Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton SO17 6YD, UK. · Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen 91054, Germany. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA 02115, USA. · Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund 222 42, Sweden. · Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig 04107, Germany; LIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig 04103, Germany. · Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9WL, UK; North West Genomic Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester M13 9WL, UK. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen 91054, Germany; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA 90095, USA. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20850, USA; Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh Medical School, Edinburgh EH16 4TJ, UK; Cancer Research UK Edinburgh Centre, Edinburgh EH4 2XR, UK. · The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW7 3RP, UK. · Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev 2730, Denmark. · Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany; Center for Primary Health Care Research, Clinical Research Center, Lund University, Malmö 205 02, Sweden. · School of Public Health, Curtin University, Perth, WA 6102, Australia. · Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela 15706, Spain; Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA. · Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid 28040, Spain. · Department of Medical Oncology, University Hospital of Heraklion, Heraklion 711 10, Greece. · Cancer Epidemiology & Intelligence Division, Cancer Council Victoria, Melbourne, VIC 3004, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC 3010, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC 3004, Australia. · Institute of Biochemistry and Genetics, Ufa Scientific Center of Russian Academy of Sciences, Ufa 450054, Russia; Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa 450076, Russia. · Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada. · Department of Medicine, McGill University, Montréal, QC H4A 3J1, Canada; Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University, Montréal, QC H4A 3J1, Canada. · Department of Dermatology and Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT 84112, USA. · Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo 0379, Norway. · Department of Surgery, Oulu University Hospital, University of Oulu, Oulu 90220, Finland. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin 71-252, Poland. · Centre de Recherche du Centre Hospitalier de Université de Montréal (CHUM), Université de Montréal, Montréal, QC H2X 0A9, Canada. · Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne 50937, Germany; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne 50931, Germany. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. · Institute of Environmental Medicine, Karolinska Institutet, Stockholm 171 77, Sweden. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany. · Department of Biostatistics & Epidemiology, University of Massachusetts, Amherst, Amherst, MA 1003, USA. · Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, UK; Nightingale Breast Screening Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester M23 9LT, UK; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester M13 9WL, UK. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA. · School of Population and Global Health, University of Western Australia, Perth, WA 6009, Australia. · Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam 3015 CN, the Netherlands. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC 3010, Australia. · Division of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK. · Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA 02115, USA; Program in Genetic Epidemiology and Statistical Genetics, Harvard TH Chan School of Public Health, Boston, MA 02115, USA; Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK. · Research Centre for Genetic Engineering and Biotechnology "Georgi D. Efremov," Macedonian Academy of Sciences and Arts, Skopje 1000, Republic of Macedonia. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin 71-252, Poland; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin 71-252, Poland. · Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm 89075, Germany. · Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94304, USA. · Division of Genetics and Epidemiology, The Institute of Cancer Research, London SM2 5NG, UK. · Department of Oncology, Tampere University Hospital, Tampere, Finland Box 2000, 33521 Tampere, Finland. · Translational Cancer Research Area, University of Eastern Finland, Kuopio 70210, Finland; Central Finland Health Care District, Jyväskylä Central Hospital, Jyväskylä 40620, Finland. · Surgery, School of Medicine, National University of Ireland, Galway H91TK33, Ireland. · Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki 00290, Finland. · Prosserman Centre for Population Health Research, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON M5T 3L9, Canada; Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5T 3M7, Canada. · Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn 53177, Germany. · Translational Cancer Research Area, University of Eastern Finland, Kuopio 70210, Finland; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio 70210, Finland; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio 70210, Finland. · Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany. · VIB Center for Cancer Biology, VIB, Leuven 3000, Belgium; Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven 3000, Belgium. · Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI 96813, USA. · Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa 35254, Israel. · Department of Molecular Medicine and Surgery, Karolinska Institutet, and Department of Clinical Genetics, Karolinska University Hospital, Stockholm 171 76, Sweden. · Department of Epidemiology, University of Washington School of Public Health, Seattle, WA 98195, USA; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. · Department of Cancer Epidemiology and Prevention, M Sklodowska-Curie Cancer Center - Oncology Institute, Warsaw 02-034, Poland. · Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart 70376, Germany; University of Tübingen, Tübingen 72074, Germany. · German Breast Group, GmbH, Neu Isenburg 63263, Germany. · Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. · Cancer Epidemiology & Intelligence Division, Cancer Council Victoria, Melbourne, VIC 3004, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC 3010, Australia. · Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan 20133, Italy. · Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm 118 83, Sweden; Department of Oncology, Södersjukhuset, Stockholm 118 83, Sweden. · Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA; Department of Family Medicine and Public Health, University of California San Diego, La Jolla, CA 92093, USA. · Anatomical Pathology, The Alfred Hospital, Melbourne, VIC 3004, Australia. · Department of Gynecology and Obstetrics, Ludwig Maximilian University of Munich, Munich 80336, Germany. · MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London WC1V 6LJ, UK. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany; Faculty of Medicine, University of Heidelberg, Heidelberg 69120, Germany. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada; Laboratory Medicine Program, University Health Network, Toronto, ON M5G 2C4, Canada. · Université Paris Sorbonne Cité, INSERM UMR-S1147, Paris 75270, France. · Radiation Oncology, Hospital Meixoeiro-XXI de Vigo, Vigo 36214, Spain. · Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven 3000, Belgium. · Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev 2730, Denmark; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev 2730, Denmark. · Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast BT7 1NN, UK. · University of New Mexico Health Sciences Center, University of New Mexico, Albuquerque, NM 87131, USA. · Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo 33012, Spain. · Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid 28222, Spain. · Genome Diagnostic Program, IFOM the FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan 20139, Italy. · Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. · Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa 450076, Russia. · Department of Oncology, Wayne State University School of Medicine, Detroit, MI 48201, USA. · Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu 90220, Finland; Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu 90220, Finland. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan 20133, Italy. · Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA. · Department of Oncology, University Hospital of Larissa, Larissa 711 10, Greece. · Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27709, USA. · Research Oncology, Guy's Hospital, King's College London, London SE1 9RT, UK. · Pubmed 30554720
2018
  • Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Department of Electron Microscopy/Molecular Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus. · Department of Molecular Physiology & Biophysics, Vanderbilt Genetics Institute, Vanderbilt University, Nashville, TN, USA. · Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA. · Department of Medicine, Harvard Medical School, Boston, MA, USA. · Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA. · Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada. · Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada. · Department of Epidemiology, University of California Irvine, Irvine, CA, USA. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Public Health Sciences, and Cancer Research Institute, Queen's University, Kingston, Ontario, Canada. · Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, WI, USA. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain. · Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain. · Institute of Biochemistry and Genetics, Ufa Scientific Center of Russian Academy of Sciences, Ufa, Russia. · Gynaecology Research Unit, Hannover Medical School, Hannover, Germany. · Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Department of Oncology, University of Örebro, Örebro, Sweden. · Department of Radiation Oncology, Hannover Medical School, Hannover, Germany. · N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus. · Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany. · University of Tübingen, Tübingen, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. · Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden. · Department of Gynecology and Obstetrics, University of Tübingen, Tübingen, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. · Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Medical Oncology Department, CIBERONC Hospital Clínico San Carlos, Madrid, Spain. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA. · Oncology and Genetics Unit, Instituto de Investigacion Biomedica Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain. · University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Epidemiology, University of Florida, Gainesville, FL, USA. · Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. · INSERM U1052, Cancer Research Center of Lyon, Lyon, France. · Sheffield Institute for Nucleic Acids, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA. · Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Center for Inherited Disease Research (CIDR), Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. · Genomics Center, Centre Hospitalier Universitaire de Québec - Université Laval Research Center, Québec City, QC, Canada. · Department of Biomedical Sciences, Faculty of Science and Technology, University of Westminster, London, UK. · Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany. · David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA, USA. · Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh Medical School, Edinburgh, UK. · Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Cancer Epidemiology, Clinical Cancer Registry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK. · Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · School of Public Health, Curtin University, Perth, Western Australia, Australia. · Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago De Compostela, Spain. · Moores Cancer Center, University of California San Diego, La Jolla, CA, USA. · Cancer Epidemiology & Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia. · Department of Medicine, McGill University, Montréal, Quebec, Canada. · Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University, Montréal, Quebec, Canada. · Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA. · Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France. · Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany. · Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. · Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. · Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. · Department of Oncology, Södersjukhuset, Stockholm, Sweden. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. · Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Nuffield Department of Population Health, University of Oxford, Big Data Institute, Oxford, UK. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland. · Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany. · Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA, USA. · Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, CA, USA. · Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. · Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. · School of Medicine, National University of Ireland, Galway, Ireland. · Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa, Russia. · Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland. · Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Clinical Molecular Biology, Oslo University Hospital, University of Oslo, Oslo, Norway. · VIB KULeuven Center for Cancer Biology, VIB, Leuven, Belgium. · Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium. · Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA. · Human Genetics, Genome Institute of Singapore, Singapore, Singapore. · Department of Epidemiology, University of Washington School of Public Health, Seattle, WA, USA. · Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland. · German Breast Group, GmbH, Neu Isenburg, Germany. · Southampton Clinical Trials Unit, University of Southampton, Southampton, UK. · Research Centre for Genetic Engineering and Biotechnology "Georgi D. Efremov", Macedonian Academy of Sciences and Arts, Skopje, Macedonia. · Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden. · Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece. · Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands. · Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany. · Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. · Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA. · Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. · Center for Clinical Cancer Genetics and Global Health, The University of Chicago, Chicago, IL, USA. · IFOM, The FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy. · Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland. · Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu, Finland. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy. · Section of Cancer Genetics, The Institute of Cancer Research, London, UK. · Department of Community Medicine and Epidemiology, Carmel Medical Center, Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology and Clalit National Cancer Control Center, Haifa, Israel. · Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain. · Hereditary Cancer Clinic, University Hospital of Heraklion, Heraklion, Greece. · Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA. · Research Oncology, Guy's Hospital, King's College London, London, UK. · Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany. · Division of Molecular Medicine, Pathology North, John Hunter Hospital, Newcastle, New South Wales, Australia. · Discipline of Medical Genetics, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Newcastle, New South Wales, Australia. · Department of Pathology, The University of Melbourne, Melbourne, Victoria, Australia. · Cancer Control Research, BC Cancer Agency, Vancouver, British Columbia, Canada. · School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. · The Curtin UWA Centre for Genetic Origins of Health and Disease, Curtin University and University of Western Australia, Perth, Western Australia, Australia. · Department of Obstetrics and Gynaecology, University of Melbourne and the Royal Women's Hospital, Melbourne, Victoria, Australia. · Division of Breast Cancer Research, The Institute of Cancer Research, London, UK. · Epigenetic and Stem Cell Biology Laboratory, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA. · Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA. · McGill University and Génome Québec Innovation Centre, Montréal, Quebec, Canada. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia. · Department of Gynecology and Obstetrics, Helios Clinics Berlin-Buch, Berlin, Germany. · Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA. · Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Department of Medicine, Institute for Human Genetics, UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · Pubmed 29915430
  • Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA. · Seidman Cancer Center, University Hospitals, Cleveland, OH, USA. · Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK. · Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA. · Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK. · Institute of Cancer Research, London, UK. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, USA. · Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica, CIBERER, IDIS, Santiago de Compostela, Spain. · Department of Oncology, Centre for Cancer Genetic Epidemiology, Strangeways Laboratory, University of Cambridge, Cambridge, UK. · Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, UK. · Warwick Medical School, University of Warwick, Coventry, UK. · Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA. · SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · CHRISTUS Santa Rosa Hospital-Medical Center, San Antonio, TX, USA. · Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia. · Australian Prostate Cancer Research Centre-Qld, Translational Research Institute, Brisbane, Queensland, Australia. · Menzies Health Institute of Queensland, Griffith University, Nathan, Queensland, Australia. · Cancer Council Queensland, Fortitude Valley, Queensland, Australia. · Chris O'Brien Lifehouse (COBLH), Camperdown, New South Wales, Australia. · Garvan Institute of Medical Research, Sydney, New South Wales, Australia. · Dame Roma Mitchell Cancer Research Centre, University of Adelaide, Adelaide, South Australia, Australia. · Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Program, Department of Anatomy and Developmental Biology, Monash University, Victoria, Australia. · Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Department of Urology, Karolinska University Hospital, Stockholm, Sweden. · Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. · Department of Clinical Sciences at Danderyds Hospital, Karolinska Institutet, Stockholm, Sweden. · Department of Applied Health Research, University College London, London, UK. · Institute of Biomedicine, University of Turku, Turku, Finland. · Tyks Microbiology and Genetics, Department of Medical Genetics, Turku University Hospital, Turku, Finland. · Department of Urology, Tampere University Hospital and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland. · Department of Epidemiology, School of Health Sciences, University of Tampere, Tampere, Finland. · Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. · Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. · Division of Cancer Sciences, Manchester Cancer Research Centre, Manchester Academic Health Science Centre and Christie NHS Foundation Trust, University of Manchester, Manchester, UK. · Department of Oncology, Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, University of Cambridge, Cambridge, UK. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Washington University School of Medicine, St. Louis, MO, USA. · UPMC Sorbonne Universités, GRC no. 5 ONCOTYPE-URO, Tenon Hospital, Paris, France. · CeRePP, Tenon Hospital, Paris, France. · Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark. · Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. · Department of Urology, Aarhus University Hospital, Aarhus, Denmark. · Department of Medical Genetics, Oslo University Hospital, Oslo, Norway. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK. · Cancer Research UK, Cambridge Research Institute, Cambridge, UK. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK, Faculty of Medical Science, John Radcliffe Hospital, University of Oxford, Oxford, UK. · School of Social and Community Medicine, University of Bristol, Bristol, UK. · Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK. · Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Division of Urology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY, USA. · Department of Pathology, Albert Einstein College of Medicine, Bronx, NY, USA. · Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. · Second Military Medical University, Shanghai, China. · Wuxi Second Hospital, Nanjing Medical University, Wuxi, China. · Department of Urology, First Affiliated Hospital, Chongqing Medical University, Chongqing, China. · Department of Urology, Zhongshan Hospital, Fudan University Medical College, Shanghai, China. · People's Hospital of Liaoning Province, People's Hospital of China Medical University, Shenyang, China. · Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia. · Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia. · Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia. · Division of Urologic Surgery, Brigham and Womens Hospital, Boston, MA, USA. · Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain. · Division of Family Medicine, Department of Neurobiology, Care Science and Society, Karolinska, Institutet, Huddinge, Sweden. · Scandinavian Development Services, Danderyd, Sweden. · ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain. · CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. · IMIM (Hospital del Mar Research Institute), Barcelona, Spain. · Universitat Pompeu Fabra (UPF), Barcelona, Spain. · University of Cantabria-IDIVAL, Santander, Spain. · Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. · Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA. · Biostatistics Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA, USA. · Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA. · International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA. · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Department of Urology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. · Saarland Cancer Registry, Saarbrücken, Germany. · Institute for Human Genetics, University Hospital Ulm, Ulm, Germany. · Department of Urology, University Hospital Ulm, Ulm, Germany. · Department of Genitourinary Medical Oncology, University of Texas-MD Anderson Cancer Center, Houston, TX, USA. · Cancer Prevention Institute of California, Fremont, CA, USA. · Department of Health Research & Policy (Epidemiology) and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. · Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal. · Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal. · Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, CA, USA. · Faculty of Medicine and Health Sciences, Basic Medical Sciences, Ghent University, Ghent, Belgium. · Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium. · Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. · Cancer Research Malaysia (CRM), Outpatient Centre, Subang Jaya Medical Centre, Selangor, Malaysia. · Department of Urology, University of Washington, Seattle, WA, USA. · Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Oncology, Division of Medical Oncology, Urogenital Unit, University Hospital Centre Zagreb, Zagreb, Croatia. · Department of Urology, University Hospital Center Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia. · Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical University of Sofia, Sofia, Bulgaria. · Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada. · Division of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada. · Department of Urology and Alexandrovska University Hospital, Medical University of Sofia, Sofia, Bulgaria. · Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium. · Department of Urology, University Hospitals Leuven, Leuven, Belgium. · University of Southampton, Southampton General Hospital, Southampton, UK. · Division of Cancer Sciences, Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Center, NIHR Manchester Biomedical Research Centre, Health Innovation Manchester, University of Manchester, Manchester, UK. · University of Surrey, Guildford, Surrey, UK. · Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servicio Galego de Saúde, SERGAS, Santiago de Compostela, Spain. · Moores Cancer Center, University of California San Diego, La Jolla, CA, USA. · Genetic Oncology Unit, CHUVI Hospital, Instituto de Investigación Biomédica Galicia Sur (IISGS), Complexo Hospitalario Universitario de Vigo, Vigo, Spain. · Department of Family Medicine and Public Health, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA. · Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands. · Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France. · Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA. · Clinical Gerontology Unit, University of Cambridge, Cambridge, UK. · Division of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA. · George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, USA. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA. · Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. · Genomics England, Queen Mary University of London, London, UK. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA. · Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA. · Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. · Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA. · Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. · Institute of Cancer Research, London, UK. · Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 29892016
2017
  • Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Department of Electron Microscopy/Molecular Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus. · Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington, USA. · Program in Genetic Epidemiology and Statistical Genetics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA. · Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · The Donnelly Centre, University of Toronto, Toronto, Ontario, Canada. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Quebec, Canada. · Department of Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee, USA. · Cancer Genomics Research Laboratory (CGR), Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA. · Division of Molecular Pathology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia. · Cancer Research UK Cambridge Research Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Department of Mathematics, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. · Center for Inherited Disease Research (CIDR), Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. · Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands. · Center for Cancer Epidemiology and Prevention, The University of Chicago, Chicago, Illinois, USA. · Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Department of Epidemiology, University of California Irvine, Irvine, California, USA. · N. N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Public Health Sciences, and Cancer Research Institute, Queen's University, Kingston, Ontario, Canada. · Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA. · McGill University and Génome Québec Innovation Centre, Montréal, Quebec, Canada. · Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain. · Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain. · Institute of Biochemistry and Genetics, Ufa Scientific Center of Russian Academy of Sciences, Ufa, Russia. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, USA. · Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Department of Radiation Oncology, Hannover Medical School, Hannover, Germany. · Gynaecology Research Unit, Hannover Medical School, Hannover, Germany. · Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany. · University of Tübingen, Tübingen, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · International Agency for Research on Cancer, Lyon, France. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA. · Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden. · Sheffield Institute for Nucleic Acids (SInFoNiA), Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. · Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada. · Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, British Columbia, Canada. · Department of Gynecology and Obstetrics, University of Tübingen, Tübingen, Germany. · Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum, Bochum, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. · Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. · Medical Oncology Department, Hospital Clínico San Carlos, IdISSC (Centro Investigacion Biomedica en Red), CIBERONC (Instituto de Investigación Sanitaria San Carlos), Madrid, Spain. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago De Compostela, Spain. · Centro de Investigación en Red de Enfermedades Raras (CIBERER) y Centro Nacional de Genotipado (CEGEN-PRB2), Universidad de Santiago de Compostela, Santiago De Compostela, Spain. · Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA. · Oncology and Genetics Unit, Instituto de Investigacion Biomedica (IBI) Orense-Pontevedra-Vigo, Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain. · Hong Kong Hereditary Breast Cancer Family Registry, Happy Valley, Hong Kong. · Department of Pathology, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong. · Division of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA. · Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore. · Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, South Korea. · Cancer Research Institute, Seoul National University, Seoul, South Korea. · Westmead Institute for Medical Research, University of Sydney, Sydney, Australia. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. · Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France. · Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. · INSERM U1052, Cancer Research Center of Lyon, Lyon, France. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. · Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA. · Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. · Southampton Clinical Trials Unit, Faculty of Medicine, University of Southampton, Southampton, UK. · Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK. · Department of Biomedical Sciences, Faculty of Science and Technology, University of Westminster, London, UK. · Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA. · Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden. · Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa, Russia. · Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany. · LIFE-Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany. · David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, California, USA. · Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh Medical School, Edinburgh, UK. · Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Cancer Epidemiology, Clinical Cancer Registry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK. · Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · School of Public Health, Curtin University, Perth, Australia. · Moores Cancer Center, University of California San Diego, La Jolla, California, USA. · Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China. · Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece. · Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia. · Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada. · Department of Medicine, McGill University, Montréal, Quebec, Canada. · Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University, Montréal, Quebec, Canada. · Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA. · Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Centre de Recherche du Centre Hospitalier de Université de Montréal (CHUM), Université de Montréal, Montréal, Quebec, Canada. · Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany. · Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. · Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. · Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Biostatistics & Epidemiology, University of Massachusetts, Amherst, Amherst, Massachusetts, USA. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA. · Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland. · Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · Department of Surgery, National University Health System, Singapore, Singapore. · School of Population Health, University of Western Australia, Perth, Australia. · Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Division of Breast Surgery, Department of Surgery, Kaohsiung Medical University, Kaohsiung, Taiwan. · Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan. · Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan. · Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan. · Division of Epidemiology, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan. · Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan. · Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany. · Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, USA. · Department of Health Research and Policy-Epidemiology, Stanford University School of Medicine, Stanford, California, USA. · Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA. · Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. · Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland. · Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea. · Department of Surgery, Nagano Matsushiro General Hospital, Nagano, Japan. · School of Medicine, National University of Ireland, Galway, Ireland. · Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Department of Surgery, Daerim Saint Mary's Hospital, Seoul, South Korea. · Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada. · Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Clinical Molecular Biology, Oslo University Hospital, University of Oslo, Oslo, Norway. · Department of Surgery, The University of Hong Kong, Pok Fu Lam, Hong Kong. · Department of Surgery, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong. · Vesalius Research Center, VIB, Leuven, Belgium. · Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium. · University of Hawaii Cancer Center, Honolulu, Hawaii, USA. · Department of Surgery, Soonchunhyang University College of Medicine and Soonchunhyang University Hospital, Seoul, South Korea. · Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center, Seoul, South Korea. · Department of Cardiac, Thoracic and Vascular Surgery, National University Health System, Singapore, Singapore. · Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel. · Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. · Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center & Institute of Oncology, Warsaw, Poland. · German Breast Group GmbH, Neu Isenburg, Germany. · Division of Health Sciences, Warwick Medical School, Warwick University, Coventry, UK. · Institute of Population Health, University of Manchester, Manchester, UK. · Division of Public Health Sciences, Epidemiology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · Research Centre for Genetic Engineering and Biotechnology "Georgi D. Efremov", Macedonian Academy of Sciences and Arts, Skopje, Republic of Macedonia. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy. · Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia. · Department of Family Medicine and Public Health, University of California San Diego, La Jolla, California, USA. · Division of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan. · Anatomical Pathology, The Alfred Hospital, Melbourne, Australia. · Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany. · Servicio de Anatomía Patológica, Hospital Monte Naranco, Oviedo, Spain. · Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, London, UK. · Breast Cancer Research Unit, Cancer Research Institute, University Malaya Medical Centre, Kuala Lumpur, Malaysia. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. · Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada. · Université Paris Sorbonne Cité, INSERM UMR-S1147, Paris, France. · Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. · Department of Surgery, Seoul National University College of Medicine, Seoul, South Korea. · Center for Clinical Cancer Genetics and Global Health, The University of Chicago, Chicago, Illinois, USA. · University of New Mexico Health Sciences Center, University of New Mexico, Albuquerque, New Mexico, USA. · The Curtin UWA Centre for Genetic Origins of Health and Disease, Curtin University and University of Western Australia, Perth, Australia. · Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain. · IFOM, The FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy. · Peter MacCallum Cancer Center, Melbourne, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. · Department of Medicine, St Vincent's Hospital, The University of Melbourne, Fitzroy, Australia. · Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland. · Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu, Finland. · Department of Gynecology and Obstetrics, Ludwig-Maximilians University of Munich, Munich, Germany. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy. · Section of Cancer Genetics, The Institute of Cancer Research, London, UK. · Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain. · Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA. · Institute of Pathology, Staedtisches Klinikum Karlsruhe, Karlsruhe, Germany. · Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Pubmed 29059683
  • Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK. · Department of Electron Microscopy/Molecular Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus. · Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington, USA. · Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. · Donnelly Centre, University of Toronto, Toronto, Ontario, Canada. · Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Québec, Canada. · Department of Mathematics, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. · Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands. · Center for Inherited Disease Research (CIDR), Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. · Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK. · Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV), IRCCS, Padua, Italy. · Center for Cancer Epidemiology and Prevention, University of Chicago, Chicago, Illinois, USA. · Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Personalised Medicine Team, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Roswell Park Cancer Institute, Buffalo, New York, USA. · Center for Genomic Medicine, Department of Biomedical Data Science, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, USA. · Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada. · Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada. · Department of Epidemiology, University of California, Irvine, Irvine, California, USA. · N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Institute of Clinical Molecular Biology / Department of Gynecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany. · Department of Public Health Sciences and Cancer Research Institute, Queen's University, Kingston, Ontario, Canada. · Institute of Human Genetics, Hannover Medical School, Hannover, Germany. · Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA. · Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori (INT), Milan, Italy. · McGill University and Génome Québec Innovation Centre, Montréal, Québec, Canada. · Department of Medical Oncology, University Hospital, Vall d'Hebron, Barcelona, Spain. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · Bâtiment Cheney D, Centre Léon Bérard, Lyon, France. · Laboratory of Cell Biology, Department of Pathology, Landspitali, Reykjavik, Iceland. · BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · Human Genotyping Unit -Centro Nacional de Genotipado (CEGEN), Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. · Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Spanish Network on Rare Diseases (CIBERER), Madrid, Spain. · Institute of Biochemistry and Genetics, Ufa Scientific Center of the Russian Academy of Sciences, Ufa, Russian Federation. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, USA. · Université Clermont Auvergne, INSERM, U1240, Imagerie Moléculaire et Stratégies Théranostiques, Centre Jean Perrin, Clermont-Ferrand, France. · Clinical Cancer Genetics, City of Hope, Duarte, California, USA. · Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands. · Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. · International Epidemiology Institute, Rockville, Maryland, USA. · City of Hope Clinical Cancer Genomics Community Research Network, Duarte, California, USA. · Vesalius Research Center, VIB, Leuven, Belgium. · Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium. · Department of Radiation Oncology, Hannover Medical School, Hannover, Germany. · Gynaecology Research Unit, Hannover Medical School, Hannover, Germany. · Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark. · Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany. · University of Tübingen, Tübingen, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. · Gustave Roussy, Biopathology Department, Villejuif, France. · Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA. · Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden. · Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada. · Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, British Columbia, Canada. · Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona), Catalan Institute of Oncology, Girona, Spain. · Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. · Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Medicine, Huntsman Cancer Institute, Salt Lake City, Utah, USA. · Medical Oncology Department, CIBERONC, Hospital Clínico San Carlos, Madrid, Spain. · Section of Molecular Genetics, Department of Laboratory Medicine, University of Pisa and University Hospital of Pisa, Pisa, Italy. · Research Department, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servizo Galego de Saúde SERGAS, Santiago de Compostela, Spain. · Centro de Investigación en Red de Enfermedades Raras (CIBERER) and Centro Nacional de Genotipado (CEGEN-PRB2), Universidade de Santiago de Compostela, Santiago de Compostela, Spain. · Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA. · Oncology and Genetics Unit, Instituto de Investigación Biomédica (IBI) de Orense-Pontevedra-Vigo, Xerencia de Xestión Integrada de Vigo, Servizo Galego de Saúde SERGAS, Vigo, Spain. · Centre François Baclesse, Caen, France. · Service de Génétique Oncologique and INSERM U830, Institut Curie, Paris, France - Université Paris Descartes, Sorbonne Paris Cité. · University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Division of Cancer Prevention and Population Sciences, Roswell Park Cancer Institute, Buffalo, New York, USA. · Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec City, Québec, Canada. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia. · Huntsman Cancer Institute, Salt Lake City, Utah, USA. · Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK. · Cancer and Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France. · Division of Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Unité d'Oncogénétique, CHU Arnaud de Villeneuve, Montpellier, France. · Academic Unit of Molecular Oncology, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. · Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. · INSERM U1052, Cancer Research Center of Lyon, Lyon, France. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. · Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA. · Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK. · Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands. · Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Clinical and Molecular Genetics Area, Vall d'Hebron University Hospital, Barcelona, Spain. · Department of Gynecology and Obstetrics, Ludwig Maximilians University of Munich, Munich, Germany. · Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa. · Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. · Southampton Clinical Trials Unit, Faculty of Medicine, University of Southampton, Southampton, UK. · Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK. · Department of Biomedical Sciences, Faculty of Science and Technology, University of Westminster, London, UK. · Institute of Human Genetics, University of Münster, Münster, Germany. · Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · Department of Clinical Genetics, Lund University Hospital, Lund, Sweden. · Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Institute of Human Genetics, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. · Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany. · LIFE-Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany. · Genetics Department, Dijon University Hospital, Dijon, France. · Oncogenetics, Centre Georges-François Leclerc, Dijon, France. · Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA. · Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany. · Usher Institute of Population Health Sciences and Informatics, CRUK Edinburgh Centre, University of Edinburgh Medical School, Edinburgh, UK. · Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Cancer Epidemiology, Clinical Cancer Registry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK. · Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, Québec, Canada. · Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel. · Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel. · School of Public Health, Curtin University, Perth, Western Australia, Australia. · Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. · Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Schools of Medicine and Public Health, University of California, Los Angeles, Los Angeles, California, USA. · Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Würzburg, Germany. · Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece. · Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA. · Department of Medicine, McGill University, Montréal, Québec, Canada. · Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University, Montréal, Québec, Canada. · Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA. · Department of Obstetrics and Gynecology, Ohio State University James Comprehensive Cancer Center, Columbus, Ohio, USA. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Bethesda, Maryland, USA. · Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Centre de Recherche du Centre Hospitalier de Université de Montréal (CHUM), Montréal, Québec, Canada. · Department of Obstetrics and Gynaecology and Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria. · Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Center for Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany. · Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. · Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. · Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Biostatistics and Epidemiology, University of Massachusetts, Amherst, Amherst, Massachusetts, USA. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland. · Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Pubmed 29058716
2015
  • Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge CB1 8RN, UK; Genomic Medicine Group, CIBERER, University of Santiago de Compostela, 15706 Santiago de Compostela, Spain. · Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge CB1 8RN, UK. Electronic address: · Pubmed 25727315
Probable:    Instituto de Salud Carlos III      
2018
  • Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA. · Seidman Cancer Center, University Hospitals, Cleveland, OH, USA. · Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK. · Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA. · Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK. · Institute of Cancer Research, London, UK. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, USA. · Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica, CIBERER, IDIS, Santiago de Compostela, Spain. · Department of Oncology, Centre for Cancer Genetic Epidemiology, Strangeways Laboratory, University of Cambridge, Cambridge, UK. · Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, UK. · Warwick Medical School, University of Warwick, Coventry, UK. · Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA. · SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · CHRISTUS Santa Rosa Hospital-Medical Center, San Antonio, TX, USA. · Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia. · Australian Prostate Cancer Research Centre-Qld, Translational Research Institute, Brisbane, Queensland, Australia. · Menzies Health Institute of Queensland, Griffith University, Nathan, Queensland, Australia. · Cancer Council Queensland, Fortitude Valley, Queensland, Australia. · Chris O'Brien Lifehouse (COBLH), Camperdown, New South Wales, Australia. · Garvan Institute of Medical Research, Sydney, New South Wales, Australia. · Dame Roma Mitchell Cancer Research Centre, University of Adelaide, Adelaide, South Australia, Australia. · Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Program, Department of Anatomy and Developmental Biology, Monash University, Victoria, Australia. · Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Department of Urology, Karolinska University Hospital, Stockholm, Sweden. · Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. · Department of Clinical Sciences at Danderyds Hospital, Karolinska Institutet, Stockholm, Sweden. · Department of Applied Health Research, University College London, London, UK. · Institute of Biomedicine, University of Turku, Turku, Finland. · Tyks Microbiology and Genetics, Department of Medical Genetics, Turku University Hospital, Turku, Finland. · Department of Urology, Tampere University Hospital and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland. · Department of Epidemiology, School of Health Sciences, University of Tampere, Tampere, Finland. · Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. · Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. · Division of Cancer Sciences, Manchester Cancer Research Centre, Manchester Academic Health Science Centre and Christie NHS Foundation Trust, University of Manchester, Manchester, UK. · Department of Oncology, Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, University of Cambridge, Cambridge, UK. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Washington University School of Medicine, St. Louis, MO, USA. · UPMC Sorbonne Universités, GRC no. 5 ONCOTYPE-URO, Tenon Hospital, Paris, France. · CeRePP, Tenon Hospital, Paris, France. · Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark. · Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. · Department of Urology, Aarhus University Hospital, Aarhus, Denmark. · Department of Medical Genetics, Oslo University Hospital, Oslo, Norway. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK. · Cancer Research UK, Cambridge Research Institute, Cambridge, UK. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK, Faculty of Medical Science, John Radcliffe Hospital, University of Oxford, Oxford, UK. · School of Social and Community Medicine, University of Bristol, Bristol, UK. · Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK. · Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Division of Urology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY, USA. · Department of Pathology, Albert Einstein College of Medicine, Bronx, NY, USA. · Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. · Second Military Medical University, Shanghai, China. · Wuxi Second Hospital, Nanjing Medical University, Wuxi, China. · Department of Urology, First Affiliated Hospital, Chongqing Medical University, Chongqing, China. · Department of Urology, Zhongshan Hospital, Fudan University Medical College, Shanghai, China. · People's Hospital of Liaoning Province, People's Hospital of China Medical University, Shenyang, China. · Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia. · Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia. · Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia. · Division of Urologic Surgery, Brigham and Womens Hospital, Boston, MA, USA. · Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain. · Division of Family Medicine, Department of Neurobiology, Care Science and Society, Karolinska, Institutet, Huddinge, Sweden. · Scandinavian Development Services, Danderyd, Sweden. · ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain. · CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. · IMIM (Hospital del Mar Research Institute), Barcelona, Spain. · Universitat Pompeu Fabra (UPF), Barcelona, Spain. · University of Cantabria-IDIVAL, Santander, Spain. · Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. · Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA. · Biostatistics Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA, USA. · Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA. · International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA. · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Department of Urology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. · Saarland Cancer Registry, Saarbrücken, Germany. · Institute for Human Genetics, University Hospital Ulm, Ulm, Germany. · Department of Urology, University Hospital Ulm, Ulm, Germany. · Department of Genitourinary Medical Oncology, University of Texas-MD Anderson Cancer Center, Houston, TX, USA. · Cancer Prevention Institute of California, Fremont, CA, USA. · Department of Health Research & Policy (Epidemiology) and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. · Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal. · Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal. · Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, CA, USA. · Faculty of Medicine and Health Sciences, Basic Medical Sciences, Ghent University, Ghent, Belgium. · Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium. · Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. · Cancer Research Malaysia (CRM), Outpatient Centre, Subang Jaya Medical Centre, Selangor, Malaysia. · Department of Urology, University of Washington, Seattle, WA, USA. · Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Oncology, Division of Medical Oncology, Urogenital Unit, University Hospital Centre Zagreb, Zagreb, Croatia. · Department of Urology, University Hospital Center Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia. · Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical University of Sofia, Sofia, Bulgaria. · Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada. · Division of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada. · Department of Urology and Alexandrovska University Hospital, Medical University of Sofia, Sofia, Bulgaria. · Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium. · Department of Urology, University Hospitals Leuven, Leuven, Belgium. · University of Southampton, Southampton General Hospital, Southampton, UK. · Division of Cancer Sciences, Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Center, NIHR Manchester Biomedical Research Centre, Health Innovation Manchester, University of Manchester, Manchester, UK. · University of Surrey, Guildford, Surrey, UK. · Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servicio Galego de Saúde, SERGAS, Santiago de Compostela, Spain. · Moores Cancer Center, University of California San Diego, La Jolla, CA, USA. · Genetic Oncology Unit, CHUVI Hospital, Instituto de Investigación Biomédica Galicia Sur (IISGS), Complexo Hospitalario Universitario de Vigo, Vigo, Spain. · Department of Family Medicine and Public Health, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA. · Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands. · Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France. · Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA. · Clinical Gerontology Unit, University of Cambridge, Cambridge, UK. · Division of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA. · George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, USA. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA. · Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. · Genomics England, Queen Mary University of London, London, UK. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA. · Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA. · Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. · Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA. · Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. · Institute of Cancer Research, London, UK. · Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 29892016
2016
  • Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark. Electronic address: · Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, USA. · Department of Radiation Oncology, University of Rochester Medical Center, USA; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, USA. · Departments of Pathology and Pediatrics, Albert Einstein College of Medicine, New York, USA. · Department of Radiotherapy (Maastro Clinic), Maastricht University Medical Center, The Netherlands. · Southpoint Cancer Center, Jacksonville, USA. · Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, UK; Centre for Cancer Genetic Epidemiology, Strangeways Research Laboratory, University of Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Strangeways Research Laboratory, University of Cambridge, UK. · Institute of Cancer Sciences, University of Manchester, The Christie NHS Foundation Trust, UK. · Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, UK. · Clinical Trials & Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK. · Fundacion Publica Galega de Medicina Xenomica-SERGAS, Grupo de Medicina Xenomica-USC, IDIS, CIBERER, Santiago de Compostela, Spain. · Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain. · Department of Genetics, University of Leicester, UK. · Department of Cancer Studies, University of Leicester, UK. · Department of Basic Medical Sciences, Ghent University, Belgium. · Department of Radiotherapy, Ghent University Hospital, Belgium. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; University Cancer Center Hamburg, University (UCCH), University Medical Center Hamburg-Eppendorf, Germany. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · MRC Clinical Trials Unit at UCL, London, UK. · Department of Radiation Oncology and Medical Physics, Institut regional du Cancer Montpellier, France. · Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. · Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Canada. · Department of Radiation Oncology, British Columbia Cancer Agency Abbotsford Clinic, Canada. · Department of Radiation Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Canada. · Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Spain. · Department of Radiation Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Area of Clinical and Molecular Genetics, Vall d'Hebron University Hospital, Barcelona, Spain. · Greenebaum Cancer Center and Department of Epidemiology & Public Health, University of Maryland School of Medicine, Baltimore, USA. · Pubmed 27443449
2015
  • Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge CB1 8RN, UK; Genomic Medicine Group, CIBERER, University of Santiago de Compostela, 15706 Santiago de Compostela, Spain. · Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge CB1 8RN, UK. Electronic address: · Pubmed 25727315
2014
  • Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, UK; University of Cambridge, Department of Oncology, Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, UK. Electronic address: · Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, UK. · Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica, CIBERER, IDIS, Santiago de Compostela, Spain. · Department of Radiation Oncology, Icahn Mount Sinai School of Medicine, NY, USA. · Department of Genetics, University of Leicester, UK. · Institute of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, UK. · Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, UK. · Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK. · Department of Cancer Studies and Molecular Medicine, University Hospitals of Leicester, UK. · Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain. · The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus. · Cancer and Other Non-Infectious Diseases, MRC Clinical Trials Unit, London, UK. · Institute of Cancer Research-Clinical Trials and Statistics Unit, Sutton, UK. · Department of Clinical Oncology, Christie Hospital, Manchester, UK. · Division of Biostatistics and Bioinformatics, Greenebaum Cancer Center; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, USA. · University of Cambridge, Department of Oncology, Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, UK. · Pubmed 24785509
  • Fundación Pública Galega de Medicina Xenómica-SERGAS. Grupo de Medicina Xenómica, CIBERER, IDIS, Santiago de Compostela, Spain. · Grupo de Medicina Xenómica -USC, University of Santiago de Compostela, CIBERER, IDIS, Santiago de Compostela, Spain. · Pubmed 24686251
2013
  • Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica-USC, CIBERER, IDIS, Santiago de Compostela, Spain. · Pubmed 23150219
Probable:    Hospital Clinico Universitario de Santiago de Compostela      
2015
  • Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge CB1 8RN, UK; Genomic Medicine Group, CIBERER, University of Santiago de Compostela, 15706 Santiago de Compostela, Spain. · Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge CB1 8RN, UK. Electronic address: · Pubmed 25727315
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 12 total) written by Laura Fachal about Breast Neoplasms:

  • Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. 2019
  • A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer. 2018
  • Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. 2018
  • Association analysis identifies 65 new breast cancer risk loci. 2017
  • Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. 2017
  • Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients. 2016
  • From candidate gene studies to GWAS and post-GWAS analyses in breast cancer. 2015
  • Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers. 2014
  • A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity. 2014
  • Large genomic rearrangements of BRCA1 and BRCA2 among patients referred for genetic analysis in Galicia (NW Spain): delimitation and mechanism of three novel BRCA1 rearrangements. 2014
Show List of Full Article Records
Google Searches

Learn more about Laura Fachal using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Cambridge
Instituto de Salud Carlos III
Hospital Clinico Universitario de Santiago de Compostela
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Cambridge
2019
  • Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK. Electronic address: · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK; Department of Electron Microscopy/Molecular Pathology, The Cyprus Institute of Neurology and Genetics, 1683 Nicosia, Cyprus. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK. · Department of Mathematics and Statistics, Laval University, Québec City, QC G1V 0A6, Canada. · Family Cancer Clinic, the Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Amsterdam, 1066 CX, the Netherlands. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20850, USA. · Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki 00290, Finland. · Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada. · Department of Epidemiology, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, CA 92617, USA. · NN Alexandrov Research Institute of Oncology and Medical Radiology, Minsk 223040, Belarus. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany. · Department of Public Health Sciences, and Cancer Research Institute, Queen's University, Kingston, ON K7L 3N6, Canada. · Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, WI 53205, USA. · Cancer Center, Kuopio University Hospital, Kuopio 70210, Finland; Institute of Clinical Medicine, Oncology, University of Eastern Finland, Kuopio 70210, Finland; Translational Cancer Research Area, University of Eastern Finland, Kuopio 70210, Finland. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen 91054, Germany. · Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain; Biomedical Network on Rare Diseases (CIBERER), Madrid 28029, Spain. · Institute of Biochemistry and Genetics, Ufa Scientific Center of Russian Academy of Sciences, Ufa 450054, Russia. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA. · Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki 00290, Finland; Department of Oncology, Örebro University Hospital, Örebro 70185, Sweden. · NN Alexandrov Research Institute of Oncology and Medical Radiology, Minsk 223040, Belarus; Department of Radiation Oncology, Hannover Medical School, Hannover 30625, Germany; Gynaecology Research Unit, Hannover Medical School, Hannover 30625, Germany. · Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev 2730, Denmark; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev 2730, Denmark; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2200, Denmark. · Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan 20141, Italy. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo 0379, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo 0450, Norway. · Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart 70376, Germany; University of Tübingen, Tübingen 72074, Germany; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg 69120, Germany. · Department of Radiation Oncology, Hannover Medical School, Hannover 30625, Germany. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg 69120, Germany; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg 69120, Germany. · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London EC1M 6BQ, UK. · Sheffield Institute for Nucleic Acids (SInFoNiA), Department of Oncology and Metabolism, University of Sheffield, Sheffield S10 2TN, UK. · Genome Sciences Centre, BC Cancer Agency, Vancouver, BC V5Z 1L3, Canada; Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, BC V5A 1S6, Canada. · Department of Gynecology and Obstetrics, University of Tübingen, Tübingen 72076, Germany. · Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum 44789, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg 69120, Germany; Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany; Department of Biology, University of Pisa, Pisa 56126, Italy. · Epidemiology Research Program, American Cancer Society, Atlanta, GA 30303, USA. · Oncology and Genetics Unit, Instituto de Investigacion Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo 36312, Spain. · Division of Medical Oncology and Hematology, University of California at Los Angeles, Los Angeles, CA 90024, USA. · Westmead Institute for Medical Research, University of Sydney, Sydney, NSW 2145, Australia. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam 3015 CN, the Netherlands. · Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif 94805, France. · Division of Molecular Pathology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam 1066 CX, the Netherlands. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield S10 2TN, UK. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 171 65, Sweden. · Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. · Department of Pathology, Leiden University Medical Center, Leiden 2333 ZA, the Netherlands; Department of Human Genetics, Leiden University Medical Center, Leiden 2333 ZA, the Netherlands. · Gynaecology Research Unit, Hannover Medical School, Hannover 30625, Germany. · Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK. · Genomics Center, Centre Hospitalier Universitaire de Québec - Université Laval Research Center, Université Laval, Québec City, QC G1V 4G2, Canada. · Southampton Clinical Trials Unit, Faculty of Medicine, University of Southampton, Southampton SO17 6YD, UK; Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton SO17 6YD, UK. · School of Life Sciences, University of Westminster, London W1B 2HW, UK. · Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton SO17 6YD, UK. · Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen 91054, Germany. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA 02115, USA. · Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund 222 42, Sweden. · Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig 04107, Germany; LIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig 04103, Germany. · Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9WL, UK; North West Genomic Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester M13 9WL, UK. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen 91054, Germany; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA 90095, USA. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20850, USA; Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh Medical School, Edinburgh EH16 4TJ, UK; Cancer Research UK Edinburgh Centre, Edinburgh EH4 2XR, UK. · The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW7 3RP, UK. · Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev 2730, Denmark. · Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany; Center for Primary Health Care Research, Clinical Research Center, Lund University, Malmö 205 02, Sweden. · School of Public Health, Curtin University, Perth, WA 6102, Australia. · Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela 15706, Spain; Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA. · Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid 28040, Spain. · Department of Medical Oncology, University Hospital of Heraklion, Heraklion 711 10, Greece. · Cancer Epidemiology & Intelligence Division, Cancer Council Victoria, Melbourne, VIC 3004, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC 3010, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC 3004, Australia. · Institute of Biochemistry and Genetics, Ufa Scientific Center of Russian Academy of Sciences, Ufa 450054, Russia; Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa 450076, Russia. · Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada. · Department of Medicine, McGill University, Montréal, QC H4A 3J1, Canada; Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University, Montréal, QC H4A 3J1, Canada. · Department of Dermatology and Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT 84112, USA. · Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo 0379, Norway. · Department of Surgery, Oulu University Hospital, University of Oulu, Oulu 90220, Finland. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin 71-252, Poland. · Centre de Recherche du Centre Hospitalier de Université de Montréal (CHUM), Université de Montréal, Montréal, QC H2X 0A9, Canada. · Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne 50937, Germany; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne 50931, Germany. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. · Institute of Environmental Medicine, Karolinska Institutet, Stockholm 171 77, Sweden. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany. · Department of Biostatistics & Epidemiology, University of Massachusetts, Amherst, Amherst, MA 1003, USA. · Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, UK; Nightingale Breast Screening Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester M23 9LT, UK; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester M13 9WL, UK. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA. · School of Population and Global Health, University of Western Australia, Perth, WA 6009, Australia. · Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam 3015 CN, the Netherlands. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC 3010, Australia. · Division of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK. · Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA 02115, USA; Program in Genetic Epidemiology and Statistical Genetics, Harvard TH Chan School of Public Health, Boston, MA 02115, USA; Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK. · Research Centre for Genetic Engineering and Biotechnology "Georgi D. Efremov," Macedonian Academy of Sciences and Arts, Skopje 1000, Republic of Macedonia. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin 71-252, Poland; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin 71-252, Poland. · Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm 89075, Germany. · Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94304, USA. · Division of Genetics and Epidemiology, The Institute of Cancer Research, London SM2 5NG, UK. · Department of Oncology, Tampere University Hospital, Tampere, Finland Box 2000, 33521 Tampere, Finland. · Translational Cancer Research Area, University of Eastern Finland, Kuopio 70210, Finland; Central Finland Health Care District, Jyväskylä Central Hospital, Jyväskylä 40620, Finland. · Surgery, School of Medicine, National University of Ireland, Galway H91TK33, Ireland. · Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki 00290, Finland. · Prosserman Centre for Population Health Research, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON M5T 3L9, Canada; Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5T 3M7, Canada. · Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn 53177, Germany. · Translational Cancer Research Area, University of Eastern Finland, Kuopio 70210, Finland; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio 70210, Finland; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio 70210, Finland. · Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany. · VIB Center for Cancer Biology, VIB, Leuven 3000, Belgium; Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven 3000, Belgium. · Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI 96813, USA. · Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa 35254, Israel. · Department of Molecular Medicine and Surgery, Karolinska Institutet, and Department of Clinical Genetics, Karolinska University Hospital, Stockholm 171 76, Sweden. · Department of Epidemiology, University of Washington School of Public Health, Seattle, WA 98195, USA; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. · Department of Cancer Epidemiology and Prevention, M Sklodowska-Curie Cancer Center - Oncology Institute, Warsaw 02-034, Poland. · Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart 70376, Germany; University of Tübingen, Tübingen 72074, Germany. · German Breast Group, GmbH, Neu Isenburg 63263, Germany. · Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. · Cancer Epidemiology & Intelligence Division, Cancer Council Victoria, Melbourne, VIC 3004, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC 3010, Australia. · Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan 20133, Italy. · Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm 118 83, Sweden; Department of Oncology, Södersjukhuset, Stockholm 118 83, Sweden. · Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA; Department of Family Medicine and Public Health, University of California San Diego, La Jolla, CA 92093, USA. · Anatomical Pathology, The Alfred Hospital, Melbourne, VIC 3004, Australia. · Department of Gynecology and Obstetrics, Ludwig Maximilian University of Munich, Munich 80336, Germany. · MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London WC1V 6LJ, UK. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany; Faculty of Medicine, University of Heidelberg, Heidelberg 69120, Germany. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada; Laboratory Medicine Program, University Health Network, Toronto, ON M5G 2C4, Canada. · Université Paris Sorbonne Cité, INSERM UMR-S1147, Paris 75270, France. · Radiation Oncology, Hospital Meixoeiro-XXI de Vigo, Vigo 36214, Spain. · Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven 3000, Belgium. · Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev 2730, Denmark; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev 2730, Denmark. · Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast BT7 1NN, UK. · University of New Mexico Health Sciences Center, University of New Mexico, Albuquerque, NM 87131, USA. · Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo 33012, Spain. · Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid 28222, Spain. · Genome Diagnostic Program, IFOM the FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan 20139, Italy. · Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. · Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa 450076, Russia. · Department of Oncology, Wayne State University School of Medicine, Detroit, MI 48201, USA. · Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu 90220, Finland; Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu 90220, Finland. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan 20133, Italy. · Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA. · Department of Oncology, University Hospital of Larissa, Larissa 711 10, Greece. · Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27709, USA. · Research Oncology, Guy's Hospital, King's College London, London SE1 9RT, UK. · Pubmed 30554720
2018
  • Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Department of Electron Microscopy/Molecular Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus. · Department of Molecular Physiology & Biophysics, Vanderbilt Genetics Institute, Vanderbilt University, Nashville, TN, USA. · Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA. · Department of Medicine, Harvard Medical School, Boston, MA, USA. · Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA. · Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada. · Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada. · Department of Epidemiology, University of California Irvine, Irvine, CA, USA. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Public Health Sciences, and Cancer Research Institute, Queen's University, Kingston, Ontario, Canada. · Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, WI, USA. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain. · Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain. · Institute of Biochemistry and Genetics, Ufa Scientific Center of Russian Academy of Sciences, Ufa, Russia. · Gynaecology Research Unit, Hannover Medical School, Hannover, Germany. · Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Department of Oncology, University of Örebro, Örebro, Sweden. · Department of Radiation Oncology, Hannover Medical School, Hannover, Germany. · N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus. · Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany. · University of Tübingen, Tübingen, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. · Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden. · Department of Gynecology and Obstetrics, University of Tübingen, Tübingen, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. · Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Medical Oncology Department, CIBERONC Hospital Clínico San Carlos, Madrid, Spain. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA. · Oncology and Genetics Unit, Instituto de Investigacion Biomedica Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain. · University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Epidemiology, University of Florida, Gainesville, FL, USA. · Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. · INSERM U1052, Cancer Research Center of Lyon, Lyon, France. · Sheffield Institute for Nucleic Acids, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA. · Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Center for Inherited Disease Research (CIDR), Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. · Genomics Center, Centre Hospitalier Universitaire de Québec - Université Laval Research Center, Québec City, QC, Canada. · Department of Biomedical Sciences, Faculty of Science and Technology, University of Westminster, London, UK. · Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany. · David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA, USA. · Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh Medical School, Edinburgh, UK. · Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Cancer Epidemiology, Clinical Cancer Registry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK. · Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · School of Public Health, Curtin University, Perth, Western Australia, Australia. · Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago De Compostela, Spain. · Moores Cancer Center, University of California San Diego, La Jolla, CA, USA. · Cancer Epidemiology & Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia. · Department of Medicine, McGill University, Montréal, Quebec, Canada. · Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University, Montréal, Quebec, Canada. · Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA. · Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France. · Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany. · Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. · Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. · Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. · Department of Oncology, Södersjukhuset, Stockholm, Sweden. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. · Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Nuffield Department of Population Health, University of Oxford, Big Data Institute, Oxford, UK. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland. · Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany. · Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA, USA. · Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, CA, USA. · Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. · Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. · School of Medicine, National University of Ireland, Galway, Ireland. · Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa, Russia. · Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland. · Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Clinical Molecular Biology, Oslo University Hospital, University of Oslo, Oslo, Norway. · VIB KULeuven Center for Cancer Biology, VIB, Leuven, Belgium. · Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium. · Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA. · Human Genetics, Genome Institute of Singapore, Singapore, Singapore. · Department of Epidemiology, University of Washington School of Public Health, Seattle, WA, USA. · Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland. · German Breast Group, GmbH, Neu Isenburg, Germany. · Southampton Clinical Trials Unit, University of Southampton, Southampton, UK. · Research Centre for Genetic Engineering and Biotechnology "Georgi D. Efremov", Macedonian Academy of Sciences and Arts, Skopje, Macedonia. · Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden. · Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece. · Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands. · Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany. · Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. · Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA. · Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. · Center for Clinical Cancer Genetics and Global Health, The University of Chicago, Chicago, IL, USA. · IFOM, The FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy. · Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland. · Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu, Finland. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy. · Section of Cancer Genetics, The Institute of Cancer Research, London, UK. · Department of Community Medicine and Epidemiology, Carmel Medical Center, Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology and Clalit National Cancer Control Center, Haifa, Israel. · Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain. · Hereditary Cancer Clinic, University Hospital of Heraklion, Heraklion, Greece. · Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA. · Research Oncology, Guy's Hospital, King's College London, London, UK. · Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany. · Division of Molecular Medicine, Pathology North, John Hunter Hospital, Newcastle, New South Wales, Australia. · Discipline of Medical Genetics, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Newcastle, New South Wales, Australia. · Department of Pathology, The University of Melbourne, Melbourne, Victoria, Australia. · Cancer Control Research, BC Cancer Agency, Vancouver, British Columbia, Canada. · School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. · The Curtin UWA Centre for Genetic Origins of Health and Disease, Curtin University and University of Western Australia, Perth, Western Australia, Australia. · Department of Obstetrics and Gynaecology, University of Melbourne and the Royal Women's Hospital, Melbourne, Victoria, Australia. · Division of Breast Cancer Research, The Institute of Cancer Research, London, UK. · Epigenetic and Stem Cell Biology Laboratory, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA. · Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA. · McGill University and Génome Québec Innovation Centre, Montréal, Quebec, Canada. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia. · Department of Gynecology and Obstetrics, Helios Clinics Berlin-Buch, Berlin, Germany. · Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA. · Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Department of Medicine, Institute for Human Genetics, UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · Pubmed 29915430
  • Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA. · Seidman Cancer Center, University Hospitals, Cleveland, OH, USA. · Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK. · Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA. · Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK. · Institute of Cancer Research, London, UK. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, USA. · Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica, CIBERER, IDIS, Santiago de Compostela, Spain. · Department of Oncology, Centre for Cancer Genetic Epidemiology, Strangeways Laboratory, University of Cambridge, Cambridge, UK. · Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, UK. · Warwick Medical School, University of Warwick, Coventry, UK. · Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA. · SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · CHRISTUS Santa Rosa Hospital-Medical Center, San Antonio, TX, USA. · Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia. · Australian Prostate Cancer Research Centre-Qld, Translational Research Institute, Brisbane, Queensland, Australia. · Menzies Health Institute of Queensland, Griffith University, Nathan, Queensland, Australia. · Cancer Council Queensland, Fortitude Valley, Queensland, Australia. · Chris O'Brien Lifehouse (COBLH), Camperdown, New South Wales, Australia. · Garvan Institute of Medical Research, Sydney, New South Wales, Australia. · Dame Roma Mitchell Cancer Research Centre, University of Adelaide, Adelaide, South Australia, Australia. · Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Program, Department of Anatomy and Developmental Biology, Monash University, Victoria, Australia. · Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Department of Urology, Karolinska University Hospital, Stockholm, Sweden. · Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. · Department of Clinical Sciences at Danderyds Hospital, Karolinska Institutet, Stockholm, Sweden. · Department of Applied Health Research, University College London, London, UK. · Institute of Biomedicine, University of Turku, Turku, Finland. · Tyks Microbiology and Genetics, Department of Medical Genetics, Turku University Hospital, Turku, Finland. · Department of Urology, Tampere University Hospital and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland. · Department of Epidemiology, School of Health Sciences, University of Tampere, Tampere, Finland. · Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. · Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. · Division of Cancer Sciences, Manchester Cancer Research Centre, Manchester Academic Health Science Centre and Christie NHS Foundation Trust, University of Manchester, Manchester, UK. · Department of Oncology, Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, University of Cambridge, Cambridge, UK. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Washington University School of Medicine, St. Louis, MO, USA. · UPMC Sorbonne Universités, GRC no. 5 ONCOTYPE-URO, Tenon Hospital, Paris, France. · CeRePP, Tenon Hospital, Paris, France. · Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark. · Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. · Department of Urology, Aarhus University Hospital, Aarhus, Denmark. · Department of Medical Genetics, Oslo University Hospital, Oslo, Norway. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK. · Cancer Research UK, Cambridge Research Institute, Cambridge, UK. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK, Faculty of Medical Science, John Radcliffe Hospital, University of Oxford, Oxford, UK. · School of Social and Community Medicine, University of Bristol, Bristol, UK. · Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK. · Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Division of Urology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY, USA. · Department of Pathology, Albert Einstein College of Medicine, Bronx, NY, USA. · Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. · Second Military Medical University, Shanghai, China. · Wuxi Second Hospital, Nanjing Medical University, Wuxi, China. · Department of Urology, First Affiliated Hospital, Chongqing Medical University, Chongqing, China. · Department of Urology, Zhongshan Hospital, Fudan University Medical College, Shanghai, China. · People's Hospital of Liaoning Province, People's Hospital of China Medical University, Shenyang, China. · Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia. · Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia. · Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia. · Division of Urologic Surgery, Brigham and Womens Hospital, Boston, MA, USA. · Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain. · Division of Family Medicine, Department of Neurobiology, Care Science and Society, Karolinska, Institutet, Huddinge, Sweden. · Scandinavian Development Services, Danderyd, Sweden. · ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain. · CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. · IMIM (Hospital del Mar Research Institute), Barcelona, Spain. · Universitat Pompeu Fabra (UPF), Barcelona, Spain. · University of Cantabria-IDIVAL, Santander, Spain. · Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. · Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA. · Biostatistics Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA, USA. · Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA. · International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA. · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Department of Urology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. · Saarland Cancer Registry, Saarbrücken, Germany. · Institute for Human Genetics, University Hospital Ulm, Ulm, Germany. · Department of Urology, University Hospital Ulm, Ulm, Germany. · Department of Genitourinary Medical Oncology, University of Texas-MD Anderson Cancer Center, Houston, TX, USA. · Cancer Prevention Institute of California, Fremont, CA, USA. · Department of Health Research & Policy (Epidemiology) and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. · Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal. · Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal. · Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, CA, USA. · Faculty of Medicine and Health Sciences, Basic Medical Sciences, Ghent University, Ghent, Belgium. · Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium. · Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. · Cancer Research Malaysia (CRM), Outpatient Centre, Subang Jaya Medical Centre, Selangor, Malaysia. · Department of Urology, University of Washington, Seattle, WA, USA. · Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Oncology, Division of Medical Oncology, Urogenital Unit, University Hospital Centre Zagreb, Zagreb, Croatia. · Department of Urology, University Hospital Center Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia. · Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical University of Sofia, Sofia, Bulgaria. · Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada. · Division of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada. · Department of Urology and Alexandrovska University Hospital, Medical University of Sofia, Sofia, Bulgaria. · Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium. · Department of Urology, University Hospitals Leuven, Leuven, Belgium. · University of Southampton, Southampton General Hospital, Southampton, UK. · Division of Cancer Sciences, Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Center, NIHR Manchester Biomedical Research Centre, Health Innovation Manchester, University of Manchester, Manchester, UK. · University of Surrey, Guildford, Surrey, UK. · Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servicio Galego de Saúde, SERGAS, Santiago de Compostela, Spain. · Moores Cancer Center, University of California San Diego, La Jolla, CA, USA. · Genetic Oncology Unit, CHUVI Hospital, Instituto de Investigación Biomédica Galicia Sur (IISGS), Complexo Hospitalario Universitario de Vigo, Vigo, Spain. · Department of Family Medicine and Public Health, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA. · Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands. · Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France. · Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA. · Clinical Gerontology Unit, University of Cambridge, Cambridge, UK. · Division of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA. · George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, USA. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA. · Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. · Genomics England, Queen Mary University of London, London, UK. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA. · Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA. · Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. · Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA. · Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. · Institute of Cancer Research, London, UK. · Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 29892016
2017
  • Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Department of Electron Microscopy/Molecular Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus. · Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington, USA. · Program in Genetic Epidemiology and Statistical Genetics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA. · Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · The Donnelly Centre, University of Toronto, Toronto, Ontario, Canada. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Quebec, Canada. · Department of Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee, USA. · Cancer Genomics Research Laboratory (CGR), Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA. · Division of Molecular Pathology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia. · Cancer Research UK Cambridge Research Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Department of Mathematics, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. · Center for Inherited Disease Research (CIDR), Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. · Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands. · Center for Cancer Epidemiology and Prevention, The University of Chicago, Chicago, Illinois, USA. · Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Department of Epidemiology, University of California Irvine, Irvine, California, USA. · N. N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Public Health Sciences, and Cancer Research Institute, Queen's University, Kingston, Ontario, Canada. · Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA. · McGill University and Génome Québec Innovation Centre, Montréal, Quebec, Canada. · Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain. · Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain. · Institute of Biochemistry and Genetics, Ufa Scientific Center of Russian Academy of Sciences, Ufa, Russia. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, USA. · Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Department of Radiation Oncology, Hannover Medical School, Hannover, Germany. · Gynaecology Research Unit, Hannover Medical School, Hannover, Germany. · Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany. · University of Tübingen, Tübingen, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · International Agency for Research on Cancer, Lyon, France. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA. · Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden. · Sheffield Institute for Nucleic Acids (SInFoNiA), Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. · Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada. · Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, British Columbia, Canada. · Department of Gynecology and Obstetrics, University of Tübingen, Tübingen, Germany. · Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum, Bochum, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. · Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. · Medical Oncology Department, Hospital Clínico San Carlos, IdISSC (Centro Investigacion Biomedica en Red), CIBERONC (Instituto de Investigación Sanitaria San Carlos), Madrid, Spain. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago De Compostela, Spain. · Centro de Investigación en Red de Enfermedades Raras (CIBERER) y Centro Nacional de Genotipado (CEGEN-PRB2), Universidad de Santiago de Compostela, Santiago De Compostela, Spain. · Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA. · Oncology and Genetics Unit, Instituto de Investigacion Biomedica (IBI) Orense-Pontevedra-Vigo, Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain. · Hong Kong Hereditary Breast Cancer Family Registry, Happy Valley, Hong Kong. · Department of Pathology, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong. · Division of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA. · Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore. · Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, South Korea. · Cancer Research Institute, Seoul National University, Seoul, South Korea. · Westmead Institute for Medical Research, University of Sydney, Sydney, Australia. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. · Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France. · Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. · INSERM U1052, Cancer Research Center of Lyon, Lyon, France. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. · Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA. · Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. · Southampton Clinical Trials Unit, Faculty of Medicine, University of Southampton, Southampton, UK. · Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK. · Department of Biomedical Sciences, Faculty of Science and Technology, University of Westminster, London, UK. · Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA. · Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden. · Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa, Russia. · Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany. · LIFE-Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany. · David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, California, USA. · Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh Medical School, Edinburgh, UK. · Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Cancer Epidemiology, Clinical Cancer Registry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK. · Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · School of Public Health, Curtin University, Perth, Australia. · Moores Cancer Center, University of California San Diego, La Jolla, California, USA. · Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China. · Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece. · Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia. · Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada. · Department of Medicine, McGill University, Montréal, Quebec, Canada. · Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University, Montréal, Quebec, Canada. · Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA. · Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Centre de Recherche du Centre Hospitalier de Université de Montréal (CHUM), Université de Montréal, Montréal, Quebec, Canada. · Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany. · Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. · Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. · Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Biostatistics & Epidemiology, University of Massachusetts, Amherst, Amherst, Massachusetts, USA. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA. · Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland. · Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · Department of Surgery, National University Health System, Singapore, Singapore. · School of Population Health, University of Western Australia, Perth, Australia. · Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Division of Breast Surgery, Department of Surgery, Kaohsiung Medical University, Kaohsiung, Taiwan. · Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan. · Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan. · Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan. · Division of Epidemiology, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan. · Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan. · Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany. · Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, USA. · Department of Health Research and Policy-Epidemiology, Stanford University School of Medicine, Stanford, California, USA. · Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA. · Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. · Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland. · Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea. · Department of Surgery, Nagano Matsushiro General Hospital, Nagano, Japan. · School of Medicine, National University of Ireland, Galway, Ireland. · Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Department of Surgery, Daerim Saint Mary's Hospital, Seoul, South Korea. · Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada. · Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Clinical Molecular Biology, Oslo University Hospital, University of Oslo, Oslo, Norway. · Department of Surgery, The University of Hong Kong, Pok Fu Lam, Hong Kong. · Department of Surgery, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong. · Vesalius Research Center, VIB, Leuven, Belgium. · Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium. · University of Hawaii Cancer Center, Honolulu, Hawaii, USA. · Department of Surgery, Soonchunhyang University College of Medicine and Soonchunhyang University Hospital, Seoul, South Korea. · Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center, Seoul, South Korea. · Department of Cardiac, Thoracic and Vascular Surgery, National University Health System, Singapore, Singapore. · Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel. · Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. · Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center & Institute of Oncology, Warsaw, Poland. · German Breast Group GmbH, Neu Isenburg, Germany. · Division of Health Sciences, Warwick Medical School, Warwick University, Coventry, UK. · Institute of Population Health, University of Manchester, Manchester, UK. · Division of Public Health Sciences, Epidemiology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · Research Centre for Genetic Engineering and Biotechnology "Georgi D. Efremov", Macedonian Academy of Sciences and Arts, Skopje, Republic of Macedonia. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy. · Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia. · Department of Family Medicine and Public Health, University of California San Diego, La Jolla, California, USA. · Division of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan. · Anatomical Pathology, The Alfred Hospital, Melbourne, Australia. · Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany. · Servicio de Anatomía Patológica, Hospital Monte Naranco, Oviedo, Spain. · Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, London, UK. · Breast Cancer Research Unit, Cancer Research Institute, University Malaya Medical Centre, Kuala Lumpur, Malaysia. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. · Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada. · Université Paris Sorbonne Cité, INSERM UMR-S1147, Paris, France. · Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. · Department of Surgery, Seoul National University College of Medicine, Seoul, South Korea. · Center for Clinical Cancer Genetics and Global Health, The University of Chicago, Chicago, Illinois, USA. · University of New Mexico Health Sciences Center, University of New Mexico, Albuquerque, New Mexico, USA. · The Curtin UWA Centre for Genetic Origins of Health and Disease, Curtin University and University of Western Australia, Perth, Australia. · Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain. · IFOM, The FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy. · Peter MacCallum Cancer Center, Melbourne, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. · Department of Medicine, St Vincent's Hospital, The University of Melbourne, Fitzroy, Australia. · Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland. · Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu, Finland. · Department of Gynecology and Obstetrics, Ludwig-Maximilians University of Munich, Munich, Germany. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy. · Section of Cancer Genetics, The Institute of Cancer Research, London, UK. · Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain. · Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA. · Institute of Pathology, Staedtisches Klinikum Karlsruhe, Karlsruhe, Germany. · Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Pubmed 29059683
  • Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK. · Department of Electron Microscopy/Molecular Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus. · Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington, USA. · Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. · Donnelly Centre, University of Toronto, Toronto, Ontario, Canada. · Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Québec, Canada. · Department of Mathematics, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. · Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands. · Center for Inherited Disease Research (CIDR), Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. · Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK. · Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV), IRCCS, Padua, Italy. · Center for Cancer Epidemiology and Prevention, University of Chicago, Chicago, Illinois, USA. · Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Personalised Medicine Team, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Roswell Park Cancer Institute, Buffalo, New York, USA. · Center for Genomic Medicine, Department of Biomedical Data Science, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, USA. · Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada. · Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada. · Department of Epidemiology, University of California, Irvine, Irvine, California, USA. · N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Institute of Clinical Molecular Biology / Department of Gynecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany. · Department of Public Health Sciences and Cancer Research Institute, Queen's University, Kingston, Ontario, Canada. · Institute of Human Genetics, Hannover Medical School, Hannover, Germany. · Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA. · Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori (INT), Milan, Italy. · McGill University and Génome Québec Innovation Centre, Montréal, Québec, Canada. · Department of Medical Oncology, University Hospital, Vall d'Hebron, Barcelona, Spain. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · Bâtiment Cheney D, Centre Léon Bérard, Lyon, France. · Laboratory of Cell Biology, Department of Pathology, Landspitali, Reykjavik, Iceland. · BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · Human Genotyping Unit -Centro Nacional de Genotipado (CEGEN), Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. · Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Spanish Network on Rare Diseases (CIBERER), Madrid, Spain. · Institute of Biochemistry and Genetics, Ufa Scientific Center of the Russian Academy of Sciences, Ufa, Russian Federation. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, USA. · Université Clermont Auvergne, INSERM, U1240, Imagerie Moléculaire et Stratégies Théranostiques, Centre Jean Perrin, Clermont-Ferrand, France. · Clinical Cancer Genetics, City of Hope, Duarte, California, USA. · Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands. · Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. · International Epidemiology Institute, Rockville, Maryland, USA. · City of Hope Clinical Cancer Genomics Community Research Network, Duarte, California, USA. · Vesalius Research Center, VIB, Leuven, Belgium. · Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium. · Department of Radiation Oncology, Hannover Medical School, Hannover, Germany. · Gynaecology Research Unit, Hannover Medical School, Hannover, Germany. · Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark. · Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany. · University of Tübingen, Tübingen, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. · Gustave Roussy, Biopathology Department, Villejuif, France. · Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA. · Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden. · Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada. · Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, British Columbia, Canada. · Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona), Catalan Institute of Oncology, Girona, Spain. · Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. · Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Medicine, Huntsman Cancer Institute, Salt Lake City, Utah, USA. · Medical Oncology Department, CIBERONC, Hospital Clínico San Carlos, Madrid, Spain. · Section of Molecular Genetics, Department of Laboratory Medicine, University of Pisa and University Hospital of Pisa, Pisa, Italy. · Research Department, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servizo Galego de Saúde SERGAS, Santiago de Compostela, Spain. · Centro de Investigación en Red de Enfermedades Raras (CIBERER) and Centro Nacional de Genotipado (CEGEN-PRB2), Universidade de Santiago de Compostela, Santiago de Compostela, Spain. · Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA. · Oncology and Genetics Unit, Instituto de Investigación Biomédica (IBI) de Orense-Pontevedra-Vigo, Xerencia de Xestión Integrada de Vigo, Servizo Galego de Saúde SERGAS, Vigo, Spain. · Centre François Baclesse, Caen, France. · Service de Génétique Oncologique and INSERM U830, Institut Curie, Paris, France - Université Paris Descartes, Sorbonne Paris Cité. · University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Division of Cancer Prevention and Population Sciences, Roswell Park Cancer Institute, Buffalo, New York, USA. · Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec City, Québec, Canada. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia. · Huntsman Cancer Institute, Salt Lake City, Utah, USA. · Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK. · Cancer and Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France. · Division of Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Unité d'Oncogénétique, CHU Arnaud de Villeneuve, Montpellier, France. · Academic Unit of Molecular Oncology, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. · Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. · INSERM U1052, Cancer Research Center of Lyon, Lyon, France. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. · Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA. · Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK. · Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands. · Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Clinical and Molecular Genetics Area, Vall d'Hebron University Hospital, Barcelona, Spain. · Department of Gynecology and Obstetrics, Ludwig Maximilians University of Munich, Munich, Germany. · Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa. · Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. · Southampton Clinical Trials Unit, Faculty of Medicine, University of Southampton, Southampton, UK. · Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK. · Department of Biomedical Sciences, Faculty of Science and Technology, University of Westminster, London, UK. · Institute of Human Genetics, University of Münster, Münster, Germany. · Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · Department of Clinical Genetics, Lund University Hospital, Lund, Sweden. · Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Institute of Human Genetics, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. · Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany. · LIFE-Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany. · Genetics Department, Dijon University Hospital, Dijon, France. · Oncogenetics, Centre Georges-François Leclerc, Dijon, France. · Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA. · Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany. · Usher Institute of Population Health Sciences and Informatics, CRUK Edinburgh Centre, University of Edinburgh Medical School, Edinburgh, UK. · Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Cancer Epidemiology, Clinical Cancer Registry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK. · Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, Québec, Canada. · Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel. · Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel. · School of Public Health, Curtin University, Perth, Western Australia, Australia. · Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. · Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Schools of Medicine and Public Health, University of California, Los Angeles, Los Angeles, California, USA. · Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Würzburg, Germany. · Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece. · Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA. · Department of Medicine, McGill University, Montréal, Québec, Canada. · Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University, Montréal, Québec, Canada. · Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA. · Department of Obstetrics and Gynecology, Ohio State University James Comprehensive Cancer Center, Columbus, Ohio, USA. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Bethesda, Maryland, USA. · Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Centre de Recherche du Centre Hospitalier de Université de Montréal (CHUM), Montréal, Québec, Canada. · Department of Obstetrics and Gynaecology and Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria. · Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Center for Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany. · Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. · Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. · Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Biostatistics and Epidemiology, University of Massachusetts, Amherst, Amherst, Massachusetts, USA. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland. · Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Pubmed 29058716
2015
  • Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge CB1 8RN, UK; Genomic Medicine Group, CIBERER, University of Santiago de Compostela, 15706 Santiago de Compostela, Spain. · Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge CB1 8RN, UK. Electronic address: · Pubmed 25727315
Instituto de Salud Carlos III
2018
  • Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA. · Seidman Cancer Center, University Hospitals, Cleveland, OH, USA. · Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK. · Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA. · Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK. · Institute of Cancer Research, London, UK. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, USA. · Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica, CIBERER, IDIS, Santiago de Compostela, Spain. · Department of Oncology, Centre for Cancer Genetic Epidemiology, Strangeways Laboratory, University of Cambridge, Cambridge, UK. · Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, UK. · Warwick Medical School, University of Warwick, Coventry, UK. · Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA. · SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · CHRISTUS Santa Rosa Hospital-Medical Center, San Antonio, TX, USA. · Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia. · Australian Prostate Cancer Research Centre-Qld, Translational Research Institute, Brisbane, Queensland, Australia. · Menzies Health Institute of Queensland, Griffith University, Nathan, Queensland, Australia. · Cancer Council Queensland, Fortitude Valley, Queensland, Australia. · Chris O'Brien Lifehouse (COBLH), Camperdown, New South Wales, Australia. · Garvan Institute of Medical Research, Sydney, New South Wales, Australia. · Dame Roma Mitchell Cancer Research Centre, University of Adelaide, Adelaide, South Australia, Australia. · Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Program, Department of Anatomy and Developmental Biology, Monash University, Victoria, Australia. · Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Department of Urology, Karolinska University Hospital, Stockholm, Sweden. · Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. · Department of Clinical Sciences at Danderyds Hospital, Karolinska Institutet, Stockholm, Sweden. · Department of Applied Health Research, University College London, London, UK. · Institute of Biomedicine, University of Turku, Turku, Finland. · Tyks Microbiology and Genetics, Department of Medical Genetics, Turku University Hospital, Turku, Finland. · Department of Urology, Tampere University Hospital and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland. · Department of Epidemiology, School of Health Sciences, University of Tampere, Tampere, Finland. · Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. · Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. · Division of Cancer Sciences, Manchester Cancer Research Centre, Manchester Academic Health Science Centre and Christie NHS Foundation Trust, University of Manchester, Manchester, UK. · Department of Oncology, Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, University of Cambridge, Cambridge, UK. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Washington University School of Medicine, St. Louis, MO, USA. · UPMC Sorbonne Universités, GRC no. 5 ONCOTYPE-URO, Tenon Hospital, Paris, France. · CeRePP, Tenon Hospital, Paris, France. · Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark. · Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. · Department of Urology, Aarhus University Hospital, Aarhus, Denmark. · Department of Medical Genetics, Oslo University Hospital, Oslo, Norway. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK. · Cancer Research UK, Cambridge Research Institute, Cambridge, UK. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK, Faculty of Medical Science, John Radcliffe Hospital, University of Oxford, Oxford, UK. · School of Social and Community Medicine, University of Bristol, Bristol, UK. · Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK. · Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Division of Urology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY, USA. · Department of Pathology, Albert Einstein College of Medicine, Bronx, NY, USA. · Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. · Second Military Medical University, Shanghai, China. · Wuxi Second Hospital, Nanjing Medical University, Wuxi, China. · Department of Urology, First Affiliated Hospital, Chongqing Medical University, Chongqing, China. · Department of Urology, Zhongshan Hospital, Fudan University Medical College, Shanghai, China. · People's Hospital of Liaoning Province, People's Hospital of China Medical University, Shenyang, China. · Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia. · Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia. · Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia. · Division of Urologic Surgery, Brigham and Womens Hospital, Boston, MA, USA. · Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain. · Division of Family Medicine, Department of Neurobiology, Care Science and Society, Karolinska, Institutet, Huddinge, Sweden. · Scandinavian Development Services, Danderyd, Sweden. · ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain. · CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. · IMIM (Hospital del Mar Research Institute), Barcelona, Spain. · Universitat Pompeu Fabra (UPF), Barcelona, Spain. · University of Cantabria-IDIVAL, Santander, Spain. · Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. · Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA. · Biostatistics Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA, USA. · Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA. · International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA. · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Department of Urology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. · Saarland Cancer Registry, Saarbrücken, Germany. · Institute for Human Genetics, University Hospital Ulm, Ulm, Germany. · Department of Urology, University Hospital Ulm, Ulm, Germany. · Department of Genitourinary Medical Oncology, University of Texas-MD Anderson Cancer Center, Houston, TX, USA. · Cancer Prevention Institute of California, Fremont, CA, USA. · Department of Health Research & Policy (Epidemiology) and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. · Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal. · Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal. · Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, CA, USA. · Faculty of Medicine and Health Sciences, Basic Medical Sciences, Ghent University, Ghent, Belgium. · Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium. · Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. · Cancer Research Malaysia (CRM), Outpatient Centre, Subang Jaya Medical Centre, Selangor, Malaysia. · Department of Urology, University of Washington, Seattle, WA, USA. · Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Oncology, Division of Medical Oncology, Urogenital Unit, University Hospital Centre Zagreb, Zagreb, Croatia. · Department of Urology, University Hospital Center Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia. · Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical University of Sofia, Sofia, Bulgaria. · Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada. · Division of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada. · Department of Urology and Alexandrovska University Hospital, Medical University of Sofia, Sofia, Bulgaria. · Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium. · Department of Urology, University Hospitals Leuven, Leuven, Belgium. · University of Southampton, Southampton General Hospital, Southampton, UK. · Division of Cancer Sciences, Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Center, NIHR Manchester Biomedical Research Centre, Health Innovation Manchester, University of Manchester, Manchester, UK. · University of Surrey, Guildford, Surrey, UK. · Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servicio Galego de Saúde, SERGAS, Santiago de Compostela, Spain. · Moores Cancer Center, University of California San Diego, La Jolla, CA, USA. · Genetic Oncology Unit, CHUVI Hospital, Instituto de Investigación Biomédica Galicia Sur (IISGS), Complexo Hospitalario Universitario de Vigo, Vigo, Spain. · Department of Family Medicine and Public Health, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA. · Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands. · Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France. · Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA. · Clinical Gerontology Unit, University of Cambridge, Cambridge, UK. · Division of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA. · George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, USA. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA. · Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. · Genomics England, Queen Mary University of London, London, UK. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA. · Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA. · Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. · Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA. · Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. · Institute of Cancer Research, London, UK. · Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 29892016
2016
  • Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark. Electronic address: · Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, USA. · Department of Radiation Oncology, University of Rochester Medical Center, USA; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, USA. · Departments of Pathology and Pediatrics, Albert Einstein College of Medicine, New York, USA. · Department of Radiotherapy (Maastro Clinic), Maastricht University Medical Center, The Netherlands. · Southpoint Cancer Center, Jacksonville, USA. · Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, UK; Centre for Cancer Genetic Epidemiology, Strangeways Research Laboratory, University of Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Strangeways Research Laboratory, University of Cambridge, UK. · Institute of Cancer Sciences, University of Manchester, The Christie NHS Foundation Trust, UK. · Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, UK. · Clinical Trials & Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK. · Fundacion Publica Galega de Medicina Xenomica-SERGAS, Grupo de Medicina Xenomica-USC, IDIS, CIBERER, Santiago de Compostela, Spain. · Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain. · Department of Genetics, University of Leicester, UK. · Department of Cancer Studies, University of Leicester, UK. · Department of Basic Medical Sciences, Ghent University, Belgium. · Department of Radiotherapy, Ghent University Hospital, Belgium. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; University Cancer Center Hamburg, University (UCCH), University Medical Center Hamburg-Eppendorf, Germany. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · MRC Clinical Trials Unit at UCL, London, UK. · Department of Radiation Oncology and Medical Physics, Institut regional du Cancer Montpellier, France. · Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. · Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Canada. · Department of Radiation Oncology, British Columbia Cancer Agency Abbotsford Clinic, Canada. · Department of Radiation Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Canada. · Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Spain. · Department of Radiation Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Area of Clinical and Molecular Genetics, Vall d'Hebron University Hospital, Barcelona, Spain. · Greenebaum Cancer Center and Department of Epidemiology & Public Health, University of Maryland School of Medicine, Baltimore, USA. · Pubmed 27443449
2015
  • Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge CB1 8RN, UK; Genomic Medicine Group, CIBERER, University of Santiago de Compostela, 15706 Santiago de Compostela, Spain. · Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge CB1 8RN, UK. Electronic address: · Pubmed 25727315
2014
  • Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, UK; University of Cambridge, Department of Oncology, Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, UK. Electronic address: · Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, UK. · Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica, CIBERER, IDIS, Santiago de Compostela, Spain. · Department of Radiation Oncology, Icahn Mount Sinai School of Medicine, NY, USA. · Department of Genetics, University of Leicester, UK. · Institute of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, UK. · Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, UK. · Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK. · Department of Cancer Studies and Molecular Medicine, University Hospitals of Leicester, UK. · Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain. · The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus. · Cancer and Other Non-Infectious Diseases, MRC Clinical Trials Unit, London, UK. · Institute of Cancer Research-Clinical Trials and Statistics Unit, Sutton, UK. · Department of Clinical Oncology, Christie Hospital, Manchester, UK. · Division of Biostatistics and Bioinformatics, Greenebaum Cancer Center; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, USA. · University of Cambridge, Department of Oncology, Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, UK. · Pubmed 24785509
  • Fundación Pública Galega de Medicina Xenómica-SERGAS. Grupo de Medicina Xenómica, CIBERER, IDIS, Santiago de Compostela, Spain. · Grupo de Medicina Xenómica -USC, University of Santiago de Compostela, CIBERER, IDIS, Santiago de Compostela, Spain. · Pubmed 24686251
2013
  • Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica-USC, CIBERER, IDIS, Santiago de Compostela, Spain. · Pubmed 23150219
Hospital Clinico Universitario de Santiago de Compostela
2015
  • Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge CB1 8RN, UK; Genomic Medicine Group, CIBERER, University of Santiago de Compostela, 15706 Santiago de Compostela, Spain. · Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge CB1 8RN, UK. Electronic address: · Pubmed 25727315
Hospital Clinico San Carlos
2014
  • Genetic Counseling Unit, Department of Clinical Oncology, Hospital Clínico San Carlos, Madrid, Spain. · Pubmed 25342642
University of Otago
2013
  • Department of Pathology, University of Otago, Christchurch, New Zealand. · Pubmed 23893897
Yearly article counts 12211320000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.